合并自身免疫性甲状腺疾病对IVF-ET助孕结局的影响

doi:10.20047/j.issn1673-7210.2023.17.23

摘要
图/表
参考文献(25)
相关文章 (15)

全文: PDF (562 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨合并自身免疫性甲状腺疾病对体外受精-胚胎移植（IVF-ET）助孕结局的影响。方法选择2019年10月至2021年12月内蒙古自治区赤峰市妇产医院生殖医学中心接受IVF-ET治疗的94例甲状腺自身抗体阳性（ATA+）不孕患者为ATA+组，选择同期无自身免疫性甲状腺疾病的不孕症患者100例为对照组。两组均接受IVF-ET治疗，采用促性腺激素释放激素激动剂（GnRH-a）长方案。比较两组卵巢刺激情况，比较两组人绒毛膜促性腺激素（HCG）日优势卵泡数（≥14 mm）、雌二醇（E2）、黄体生成素（LH）、孕酮（P）水平，比较两组取卵日、移植第5天血清Th1细胞、Th2细胞水平；观察两组胚胎发育潜能及妊娠结局。结果两组HCG日优势卵泡数、E2、P水平比较，差异无统计学意义（P＞0.05）；ATA+组HCG日LH水平低于对照组（P＜0.01）。移植第5天，两组Th1、Th2、Th1/Th2均低于取卵日（P＜0.01）。取卵日及移植第5天，ATA+组Th1高于对照组，Th2、Th1/Th2低于对照组（P＜0.01）。两组获卵数、受精率、卵裂率比较，差异无统计学意义（P＞0.05）；ATA+组优质胚胎数、优质胚胎率低于对照组（P＜0.01）。两组移植胚胎数、临床妊娠率比较，差异无统计学意义（P＞0.05）；ATA+组流产率高于对照组、活产率低于对照组（P＜0.05）。结论合并自身免疫性甲状腺疾病会影响IVF-ET患者胚胎发育质量，增加流产风险，其发生机制可能与患者机体免疫改变有关。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	白利鹏　　王鑫鑫　　魏景艳　　丁立荣　　毛姝雯

关键词 ：自身免疫性甲状腺疾病, 体外受精-胚胎移植, 甲状腺自身抗体, 不孕症, 妊娠结局

Abstract：Objective To explore the effect of autoimmune thyroid disease on in vitro fertilization-embryo transfer (IVF-ET) assisted pregnancy outcome. Methods From October 2019 to December 2021, 94 infertile patients with anti-thyroid autoantibodies positive (ATA+) who received IVF-ET treatment in Reproductive Medical Center, Chifeng Maternity Hospital, Inner Mongolia Autonomous Region were selected as the ATA+ group, and 100 infertile patients without autoimmune thyroid disease in the same period were selected as the control group. Both groups received IVF-ET treatment, and gonadotropin releasing hormone antagonist (GnRH-a) long regimen was used. Ovarian stimulation was compared between the two groups, and the number of dominant follicles (≥14 mm), and the levels of estradiol (E2), luteinizing hormone (LH), progesterone (P) on the day of human chorionic gonadotropin (HCG) day between the two groups were analyzed, and the levels of serum Th1 cells and Th2 cells on the day of egg collection day and the fifth day of transplantation were analyzed; and the embryonic development potential and pregnancy outcome between the two groups were observed. Results There were no significant differences in the number of dominant follicles, and the levels of E2 and P on HCG day between the two groups (P＞0.05); the level of LH on HCG day in the ATA+ group was lower than that in the control group (P＜0.01). On the fifth day of transplantation, Th1, Th2, and Th1/Th2 in both groups were lower than those in egg collection day (P＜0.01). On egg collection day and the fifth day of transplantation, Th1 in the ATA+ group was higher than that in the control group, but Th2 and Th1/Th2 in the ATA+ group were lower than those in the control group (P＜0.01). There were no significant differences in the number of eggs, fertilization rate, and cleavage rate between the two groups (P＞0.05); the number of high-quality embryos and the rate of high-quality embryos in the ATA+ group were lower than those in the control group (P＜0.01). There were no significant differences in the number of transplanted embryos and clinical pregnancy rate between the two groups (P＞0.05). The abortion rate in the ATA+ group was higher than that in the control group, and the live birth rate was lower than that in the control group (P＜0.05). Conclusion The combination of autoimmune thyroid disease will affect the quality of embryonic development and increase the risk of abortion in IVF-ET patients, and its mechanism may be related to the immune changes of patients.

Key words： Autoimmune thyroid disease In vitro fertilization-embryo transfer Thyroid autoantibodies Infertility Pregnancy outcome

基金资助:内蒙古自治区自然科学基金面上项目（2019MS 08006）。

作者简介: 白利鹏（1982.10-），女，副主任医师；研究方向：辅助生殖。

引用本文:

白利鹏　　王鑫鑫　　魏景艳　　丁立荣　　毛姝雯. 合并自身免疫性甲状腺疾病对IVF-ET助孕结局的影响[J]. 中国医药导报, 2023, 20(17): 103-106.
BAI Lipeng WANG Xinxin WEI Jingyan DING Lirong MAO Shuwen. Effect of autoimmune thyroid disease on IVF-ET assisted pregnancy outcome. 中国医药导报, 2023, 20(17): 103-106.

链接本文:

https://www.yiyaodaobao.com.cn/CN/10.20047/j.issn1673-7210.2023.17.23 或 https://www.yiyaodaobao.com.cn/CN/Y2023/V20/I17/103

[1] Rayman MP. Multiple nutritional factors and thyroid disease，with particular reference to autoimmune thyroid disease [J]. Proc Nutr Soc，2019，78（1）：34-44.
[2] De LS，Pearce EN. Autoimmune thyroid disease during pregnancy [J]. Lancet Diabetes Endocrinol，2018 ，6（7）：575-586.
[3] Kyritsi EM，Kanaka GC. Autoimmune Thyroid Disease in Specific Genetic Syndromes in Childhood and Adolescence [J]. Front Endocrinol（Lausanne），2020，19（11）：543.
[4] Mammen JSR，Cappola AR. Autoimmune Thyroid Disease in Women [J]. JAMA，2021，15（23）：2392-2393.
[5] 娄华，马倩，付喜玲，等.基础促甲状腺素对体外受精助孕结局的影响[J].安徽医科大学学报，2018，53（12）：1938-1941.
[6] 谭忠华，樊冀伟，朱冠全.甲状腺自身抗体在自身免疫性甲状腺疾病中的临床意义[J].中华核医学杂志，2004，24（1）：51-53.
[7] 陆金春，黄宇烽.特发性精液质量异常的诊断与治疗[J].中华男科学杂志，2012，18（1）：83-86.
[8] 吴双，邓朝胜.甲状腺疾病与肺动脉高压[J].国际呼吸杂志，2019，39（17）：1357-1360.
[9] 袁宁，蔺莉，李智，等.胎次对自身免疫性甲状腺疾病的影响[J].中华内分泌代谢杂志，2018，34（8）：674-677.
[10] Knezevic J，Starchl C，Tmava BA，et al. Thyroid-Gut-Axis：How Does the Microbiota Influence Thyroid Function [J]. Nutrients，2020，12（6）：1769-1772.
[11] Vieira IH，Rodrigues D，Paiva I. Vitamin D and Autoimmune Thyroid Disease-Cause，Consequence，or a Vicious Cycle [J]. Nutrients，2020，12（9）：2791-2795.
[12] 金晓慧，李静.多囊卵巢综合征与自身免疫性甲状腺病相关性研究进展[J].中国实用内科杂志，2021，41（1）：35-39.
[13] Biondi B，Kahaly GJ，Robertson RP. Thyroid Dysfunction and Diabetes Mellitus：Two Closely Associated Disorders [J]. Endocr Rev，2019，40（3）：789-824.
[14] Vera LO，Ordinola NA，Cruz DMP，et al. Two Cases of Gra- ves’ Disease Following SARS-CoV-2 Vaccination：An Autoimmune/Inflammatory Syndrome Induced by Adjuvants [J]. Thyroid，2021，31（9）：1436-1439.
[15] Speer G，Somogyi P. Thyroid complications of SARS and cor- onavirus disease 2019（COVID-19）[J]. Endocr J，2021，68（2）：129-136.
[16] Ferrari SM，Fallahi P，Elia G，et al. Thyroid autoimmune disorders and cancer [J]. Semin Cancer Biol，2020，6（4）：135-146.
[17] Gong B，Wang C，Meng F，et al. Association Between Gut Microbiota and Autoimmune Thyroid Disease：A Systematic Review and Meta-Analysis [J]. Front Endocrinol（Lausanne），2021，17（12）：774-782.
[18] 路鸿艳，崔艳国，郝翠芳，等.CD4+T细胞在甲状腺自身抗体阳性患者中的比例及其对IVF-ET治疗结局的影响[J].实用妇产科杂志，2020，36（10）：763-768.
[19] Krysiak R，Szkrobka W，Okopien B. The Effect of Gluten- Free Diet on Thyroid Autoimmunity in Drug-Naive Women with Hashimoto’s Thyroiditis：A Pilot Study [J]. Exp Clin Endocrinol Diabetes，2019，27（7）：417-422.
[20] Frommer L，Kahaly GJ. Type 1 Diabetes and Autoimmune Thyroid Disease-The Genetic Link [J]. Front Endocrinol（Lausanne），2021，10（12）：618-623.
[21] 梁慧枝，王治鸿，杨园，等.甲状腺自身抗体阳性对甲状腺功能正常女性冻融胚胎移植妊娠结局的影响[J].中国计划生育和妇产科，2022，14（7）：50-53.
[22] 赵智宏，朴春梅，王克芳.甲状腺自身抗体阳性与不良妊娠结局的关系[J].中国医药，2021，16（11）：1696-1699.
[23] 李婧，邓垂文，徐腾达.体检人群甲状腺自身抗体与抗谷氨酸脱羧酶抗体的相关性研究[J].中国全科医学，2021，24（18）：2285-2290.
[24] 宋沁峰，李宏田，杨静，等.双胎妊娠孕早期甲状腺功能及其与早产的关联性[J].北京大学学报：医学版，2021， 53（3）：473-478.
[25] 张育婧，范晶晶，丘文漪，等.甲状腺自身免疫抗体和促甲状腺激素对行体外受精/卵胞浆内单精子注射患者妊娠结局的影响[J].新乡医学院学报，2020，37（5）：448- 452.